Clinical Trial Update: S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose melphalan with peripheral stem cell transplantation followed by interferon alfa in Waldenström's macroglobulinemia has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Melphalan (Melphalan)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: COMPLETED